• 10.01.2020 – 12:00

  Jennewein Biotechnologie GmbH

  Jennewein Biotechnologie GmbH enforces its patents in the field of human milk oligosaccharides against Nestlé in Germany

  Rheinbreitbach (ots) - Jennewein Biotechnologie GmbH filed a patent infringement suit with the regional court in Mannheim on January 09, 2020 against Nestlé Nutrition GmbH and its holding company Nestlé Deutschland AG. Nestlé offers its infant formula Beba Supreme which contains two human milk oligosaccharides - ...

  more

• 08.01.2020 – 17:00

  Jennewein Biotechnologie GmbH

  Publication of a toxicological study: a milestone for Jennewein Biotechnologie for the GRAS approval of the HMO-mix

  Rheinbreitbach (ots) - Jennewein Biotechnology announces another milestone in the Worldwide approval of a new product generation, the "HMO-Mix". The data of the toxicological study, with the title "A Safety Evaluation of Mixed Human Milk Oligosaccharides in Rats", was recently accepted for publication by the ...

  more

• 25.11.2019 – 10:13

  Jennewein Biotechnologie GmbH

  Jennewein Biotechnologie obtains US-FDA GRAS status on alternative 2'-fucosyllactose fermentation strain

  Rheinbreitbach (ots) - Jennewein Biotechnologie GmbH, Rheinbreitbach, the leading manufacturer of human milk oligosaccharides (HMOs), announces that the U.S. Food and Drug Administration (FDA) issued a "no question" response letter to Jennewein's supplement of its GRAS Notice GRN571, thereby acknowledging that the ...

  more

• 25.11.2019 – 10:02

  Jennewein Biotechnologie GmbH

  Jennewein Biotechnologie sues Glycom for patent infringement in Denmark

  Rheinbreitbach (ots) - Jennewein Biotechnologie develops fermentative processes for manufacturing of human milk oligosaccharides (HMOs) cost efficiently in an industrial scale since 2005 to make these special sugars available for affordably priced infant formula and other uses in food. Jennewein Biotechnologie was the first commercial vendor of HMOs, and brought the ...

  more

• 11.09.2019 – 17:00

  Jennewein Biotechnologie GmbH

  Administrative Law Judge issues ruling in patent dispute concerning 2'-FL production and beta-galactosidase activity

  Rheinbreitbach (ots) - On September 09, 2019, Administrative Law Judge Cameron Elliot of the US International Trade Commission issued an Initial Determination finding that one of the bacterial strains used by Jennewein Biotechnologie to make 2'-fucosyllactose (2'-FL) infringes a patent owned by Glycosyn LLC. In the ...

  more

• 01.07.2019 – 11:10

  Brenntag AG

  Brenntag EMEA distributes Borregaard's SoftAcid® and Neubacid® Soft products to animal feed industry

  Dear all, Please find attached Brenntag EMEA's press release regarding the agreement with Borregaard on the purchase, licence production and distribution of the SoftAcid® and Neubacid® Soft products to the European animal feed industry. For further information please see the press release. Please do not hesitate ...

  more

• 05.07.2018 – 12:00

  Jennewein Biotechnologie GmbH

  Jennewein Biotechnologie to build new R&D centre for synthetic organisms and microbiome research in Bonn, Germany

  Rheinbreitbach (ots) - Jennewein Biotechnologie announces that on June 15, 2018, it signed a long-term lease for a 1000-m2 plot of land on Mildred-Scheel-Straße, Bonn Bad Godesberg, which will be the site of a new R&D centre for microbiome research and designer microorganisms. "The relocation of part of our ...

  more